Renal tubular damage in rasburicase: risks of alkalinisation.

Renal tubular damage in rasburicase: risks of alkalinisation.

Item
http://www.wikidata.org/entity/Q44695885
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignanciesEmerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies.Clarifying the role of rasburicase in tumor lysis syndrome.A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.
P2860

Renal tubular damage in rasburicase: risks of alkalinisation.

Item
http://www.wikidata.org/entity/Q44695885
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Renal tubular damage in rasburicase: risks of alkalinisation.
@en
Renal tubular damage in rasburicase: risks of alkalinisation.
@nl
type
label
Renal tubular damage in rasburicase: risks of alkalinisation.
@en
Renal tubular damage in rasburicase: risks of alkalinisation.
@nl
prefLabel
Renal tubular damage in rasburicase: risks of alkalinisation.
@en
Renal tubular damage in rasburicase: risks of alkalinisation.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Renal tubular damage in rasburicase: risks of alkalinisation.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698